Table 2.
Notable differences between the Anticholinergic Drug Scale and the Anticholinergic Cognitive Burden Scale
| Anticholinergic Scoring System | Medication Prevalence | ||||
|---|---|---|---|---|---|
| Medication | Anticholinergic Drug ScoreA | Anticholinergic Cognitive Burden | Pre-hospitalization n=560 | Inpatient n=560 | Discharge n=560 |
| Amantadine | 1 | 2 | 3 (0.5%) | 0 (0%) | 3 (0.5%) |
| Doxylamine | 0 | 3 | 1 (0.2%) | 0 (0%) | 0 (0%) |
| Fesoterodine | 0 | 3 | 1 (0.2%) | 0 (0%) | 0 (0%) |
| Methocarbamol | 0 | 3 | 3 (0.5%) | 1 (0.2%) | 3 (0.5%) |
| Olanzapine | 1 | 3 | 0 (0%) | 3 (0.5%) | 1 (0.2%) |
| Paroxetine | 1 | 3 | 4 (0.7%) | 5 (0.9%) | 5 (0.9%) |
| Quetiapine | 0 | 3 | 1 (0.2%) | 7 (1.2%) | 3 (0.5%) |
| Ranitidine | 2 | 1 | 32 (5.7%) | 12 (2.1%) | 24 (4.3%) |
| Solifenacin | 0 | 3 | 6 (1.1%) | 0 (0%) | 4 (0.7%) |
| Trospium | 0 | 3 | 2 (0.4%) | 0 (0%) | 2 (0.4%) |
A
A score of 0 means that either the medication was judged to have no anticholinergic effect or was not evaluated by the scoring system.